Susquehanna International Group
ARMP icon

Susquehanna International Group’s Armata Pharmaceuticals ARMP Stock Holding History

Susquehanna International Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,300
Closed -$19.1K – 12420
2024
Q4 		$19.1K Hold
10,300
– – ﹤0.01% 11914
2024
Q3 		$24.4K Sell
10,300
-39,400
-79% -$101K ﹤0.01% 11585
2024
Q2 		$137K Buy
+49,700
New +$142K ﹤0.01% 10791

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group's ARMP Position: Q1 2026 in Review

Susquehanna International Group increased its Armata Pharmaceuticals (ARMP) stake by 166% in Q1 2026, buying an estimated $340K and bringing the position to 64,759 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #8930.

Susquehanna International Group first reported a position in ARMP in Q1 2017 and has held it in 13 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Susquehanna International Group held 64,759 shares of Armata Pharmaceuticals worth $663K as of Q1 2026.
  • Susquehanna International Group bought 40,399 Armata Pharmaceuticals shares in Q1 2026, an estimated $340K.
  • Armata Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8930 holding.
  • Susquehanna International Group first reported a position in Armata Pharmaceuticals in Q1 2017 and has held it in 13 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.